| [1] |
Wei Qing;Liu Hong;Tang Rining;Liu Bicheng.
Sevelamer on curative effect and endpoint events in hemodialysis patients--a meta analysis
[J]. Clinical Focus, 2015, 30(9): 1008-1.0121e+007.
|
| [2] |
.
[J]. Clinical Focus, 2015, 30(3): 357-360.
|
| [3] |
.
[J]. CLINICAL FOCUS, 2013, 28(9): 1060-1061.
|
| [4] |
.
[J]. Clinical Focus, 2013, 28(2): 206-208.
|
| [5] |
.
[J]. Clinical Focus, 2013, 28(1): 78-80.
|
| [6] |
CHEN Min-dong;ZHANG Yun;ZHOU Rong;FENG Xue-fang;SHEN Jie.
Elderly maintenance hemodialysis patients with erythropoietin hormone low response factors
[J]. Clinical Focus, 2012, 27(22): 1946-1.9492e+007.
|
| [7] |
.
[J]. Clinical Focus, 2012, 27(22): 1989-1991.
|
| [8] |
ZHU Hong;QI Zhen;CHEN Ji-hong.
On-line hemodiafiltration to correct calcium and phosphate metabolic disorder in uremia hemodialysis patients
[J]. Clinical Focus, 2012, 27(20): 1765-1767.
|
| [9] |
WANG Li-li;WANG Qiao-li;WANG Li-hua.
Variation of lipid in maintenance hemodialysis and relationship with insulin resistance
[J]. Clinical Focus, 2012, 27(18): 1591-1593.
|
| [10] |
LUO Dan;XIA Yuan-yu;WU Jun.
Relationship between hyperhomocysteinemia,micro inflammatory status and peripheral arterial disease in hemodialysis patients
[J]. CLINICAL FOCUS, 2011, 26(20): 1755-1758.
|
| [11] |
.
[J]. Clinical Focus, 2011, 26(17): 1519-1521.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2011, 26(1): 82-84.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2010, 25(22): 1971-1973.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(12): 1095-1096.
|
| [15] |
WANG Li-hua;MA Hui-peng;GAO Yuan.
Effect of levocarnitine on oxidative stress state in maintenance hemodialysis patients
[J]. CLINICAL FOCUS, 2009, 24(5): 413-415.
|
